Reduced density of ADAM 12-immunoreactive oligodendrocytes in the anterior cingulate white matter of patients with schizophrenia.
about
Evidence for morphological alterations in prefrontal white matter glia in schizophrenia and bipolar disorderMeta-analysis of Genome-Wide Association Studies for Extraversion: Findings from the Genetics of Personality ConsortiumOligodendrocyte morphometry and expression of myelin - Related mRNA in ventral prefrontal white matter in major depressive disorderUnderstanding aberrant white matter development in schizophrenia: an avenue for therapy?Metalloprotease (ADAM12-S) as a predictor of preeclampsia: correlation with severity, maternal complications, fetal outcome, and Doppler parameters.Essential roles of heparin-binding epidermal growth factor-like growth factor in the brain.Improving myelin/oligodendrocyte-related dysfunction: a new mechanism of antipsychotics in the treatment of schizophrenia?Extracellular matrix proteomics in schizophrenia and Alzheimer's disease.Increased density of prohibitin-immunoreactive oligodendrocytes in the dorsolateral prefrontal white matter of subjects with schizophrenia suggests extraneuronal roles for the protein in the disease.Risperidone-induced topological alterations of anatomical brain network in first-episode drug-naive schizophrenia patients: a longitudinal diffusion tensor imaging study.Association between paternal schizophrenia and low birthweight: ADAM12 may matter.Genetic variations in the ADAMTS12 gene are associated with schizophrenia in Puerto Rican patients of Spanish descent.Concerning HB-EGF brain levels in schizophrenia: cellular distribution of putative sheddases may matter.Increased density of DISC1-immunoreactive oligodendroglial cells in fronto-parietal white matter of patients with paranoid schizophrenia.
P2860
Q34429141-3FED305C-922B-4BCD-8A58-FB2595654DE1Q36573329-41C969F2-F373-4FE9-A352-817A8F77CE23Q36813144-5740EB49-C313-4E0E-BF84-846CB94B4D6CQ37896626-FB4E9B1B-EEF4-4614-A401-EB1985750D6BQ38016976-8666C1EC-8C1C-4076-B40E-F3EB5BEFD5A8Q38046005-839C5660-7B39-4C51-A392-14AF97DE3664Q38060893-5A8B6009-0F86-4AC4-B0CC-56DFAB6E53E3Q38947884-0E3AEA2B-51D7-4739-9FC8-C7BD6FF25C7DQ39328786-EB428FD0-5042-4505-80F7-71627572B08DQ42329943-3CAA5175-4F7F-4292-9F60-59EFD1DBF148Q42548278-848D3D76-B115-4186-ABF7-033EA85ECDEEQ43576204-AE9099A7-D5AF-4245-AC10-81631061AAFEQ48199720-36C271B2-995A-4734-ADB8-DA067D1B1805Q52150395-7DAA50EB-79FF-4BE3-A475-689F1FE80BE6
P2860
Reduced density of ADAM 12-immunoreactive oligodendrocytes in the anterior cingulate white matter of patients with schizophrenia.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Reduced density of ADAM 12-imm ...... f patients with schizophrenia.
@en
Reduced density of ADAM 12-imm ...... f patients with schizophrenia.
@nl
type
label
Reduced density of ADAM 12-imm ...... f patients with schizophrenia.
@en
Reduced density of ADAM 12-imm ...... f patients with schizophrenia.
@nl
prefLabel
Reduced density of ADAM 12-imm ...... f patients with schizophrenia.
@en
Reduced density of ADAM 12-imm ...... f patients with schizophrenia.
@nl
P2093
P2860
P1476
Reduced density of ADAM 12-imm ...... f patients with schizophrenia.
@en
P2093
Bernhard Bogerts
Gerburg Keilhoff
Hans-Gert Bernstein
Henrik Dobrowolny
Nadine Farkas
Sieglinde Funke
Uwe Lendeckel
P2860
P304
P356
10.3109/15622970903497936
P577
2010-04-01T00:00:00Z